In the reviewRegulating the beta cell mass as a strategy for type-2diabetes treatment [36], L.Song and co-authors indicate that modern antidiabetic therapy, which is mainlyaimed at increasing the secretion and efficacy of insulin as well as at glucoseuptake, is symptomatic. This evidence concerns the gene INS and type 2 diabetes mellitus.